Clinical Genetics · Houston, TX
NPI
1124405311
Since 2015
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
6410 Fannin St, Suite 500
Houston, TX, 77030
Phone (713) 500-5760
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.3M
63 prescriptions
Company payments, 2025
$64K
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paul Hillman prescribed most often to Medicare patients was Elaprase (Idursulfase), with 47 prescriptions and refills. In total Paul Hillman wrote 63 Medicare prescriptions that cost $2.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Elaprase Idursulfase | 47 | 47 | Under 11 | $1.7M |
Brand drugs: 61 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul Hillman $64K ($64K in general payments such as food, travel and fees) from 9 companies. The largest payer was Mirum Pharmaceuticals, Inc. with $48K.
| Company | Payments | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. MIRM | 34 | $48K |
| Chiesi USA, Inc. | 8 | $7,700 |
| Amicus Therapeutics, Inc. FOLD | 1 | $3,648 |
| Zevra Therapeutics Inc ZVRA | 3 | $3,450 |
| Genzyme Corporation SNY | 4 | $407 |
| Ultragenyx Pharmaceutical Inc. RARE | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $66.84 |
| BioMarin Pharmaceutical Inc. BMRN | 1 | $40.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.